RGTA OTR4120, a heparan sulfate mimetic, is a possible long‐term active agent to heal burned skin
Authors:
- V. Barbier‐ChassefiereVBV. Barbier‐Chassefiere
- C. AlexakisCAC. Alexakis
- E. HuetEHE. Huet
- D. LedouxDLD. Ledoux
- M. E. KerrosMKM. E. Kerros
- E. PetitEPE. Petit
- D. BarritaultDBD. Barritault
- J. P. CaruelleJCJ. P. Caruelle
- P. KernPKP. Kern
- 6 September 2006
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 80A (1) , 75-84
Abstract
Burn‐related skin fibrosis leads to loss of tissue function and hypertrophic scar formation with damaging consequences for the patient. There is therefore a great need for an efficient agent to treat burned skin. We report that ReGeneraTing Agent (RGTA) reduces burn‐induced skin alteration. The tissue‐regenerating effect of RGTA OTR4120 was evaluated after 1–6 days and after 10 months in a rat skin burn model. This effect was also examined in vitro using fibroblasts isolated from control and 6‐day‐old burned skins. We measured production of dermal collagen I, III, and V and activities of metalloproteinases 2 and 9 (MMP‐2 and MMP‐9). Ratio of collagen III over collagen I production increased 6 days after the burn, because of a decrease in collagen I production. After 10 months, ratio of collagen III over collagen I in burn sites was still increased compared with control skin, because of an increase in collagen III production. Both abnormalities were corrected by OTR4120. OTR4120 increased pro‐ and active MMP‐2 and MMP‐9, compared with healthy and burned controls and therefore accelerated remodeling. Similar data were obtained with cultured fibroblasts from healthy and burned skins. OTR4120 enhanced healing in short‐ and long‐term after burns, reducing the formation of fibrotic tissue, and then represents a potential agent to improve burned skin healing. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2007Keywords
This publication has 40 references indexed in Scilit:
- Structurally different RGTAs modulate collagen‐type expression by cultured aortic smooth muscle cells via different pathways involving fibroblast growth factor‐2 or transforming growth factor‐β1The FASEB Journal, 2004
- Increased MMP-2 Expression in Connective Tissue Growth Factor Over-expression Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2002
- Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-β1Matrix Biology, 2001
- Human Plasmin Enzymatic Activity Is Inhibited by Chemically Modified DextransJournal of Biological Chemistry, 2000
- The Hemopexin-like Domain (C Domain) of Human Gelatinase A (Matrix Metalloproteinase-2) Requires Ca2+ for Fibronectin and Heparin BindingJournal of Biological Chemistry, 1997
- Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakageJournal of Biomedical Materials Research, 1996
- The cDNA cloning and expression of the gene encoding rat gelatinase BGene, 1995
- Metalloproteinase Activation Cascade After Burn Injury: A Longitudinal Analysis of the Human Wound EnvironmentJournal of Investigative Dermatology, 1994
- Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGFJournal of Cellular Physiology, 1992
- Keloids and Hypertrophic ScarsPlastic and Reconstructive Surgery, 1989